Amedisys Reports Second Quarter 2019 Financial Results and Updates 2019 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Amedisys (AMED) Tops Q2 EPS by 3c
July 31, 2019 4:22 PM EDTAmedisys (NASDAQ: AMED) reported Q2 EPS of $1.02, $0.03 better than the analyst estimate of $0.99. Revenue for the quarter came in at $492.98 million versus the consensus estimate of $489.38 million.
Paul B. Kusserow, President and Chief Executive Officer stated, I am very proud of our... More
